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Abstract
Background: Myocardial fibrosis imaging using late gadolinium enhancement (LGE) cardiac magnetic resonance
(CMR) has been validated as a quantitative predictive marker for response to medical, surgical, and device therapy.
To date, all such studies have examined conventional, non-phase corrected magnitude images. However,
contemporary practice has rapdily adopted phase-corrected image reconstruction. We sought to investigate the
existence of any systematic bias between threshold-based scar quantification performed on conventional
magnitude inversion recovery (MIR) and matched phase sensitive inversion recovery (PSIR) images.
Methods: In 80 patients with confirmed ischemic (N = 40), or non-ischemic (n = 40) myocardial fibrosis, and also in
a healthy control cohort (N = 40) without fibrosis, myocardial late enhancement was quantified using a Signal
Threshold Versus Reference Myocardium technique (STRM) at ≥2, ≥3, and ≥5 SD threshold, and also using the Full
Width at Half Maximal (FWHM) technique. This was performed on both MIR and PSIR images and values compared
using linear regression and Bland-Altman analyses.
Results: Linear regression analysis demonstrated excellent correlation for scar volumes between MIR and PSIR
images at all three STRM signal thresholds for the ischemic (N = 40, r = 0.96, 0.95, 0.88 at 2, 3, and 5 SD, p < 0.0001
for all regressions), and non ischemic (N = 40, r = 0.86, 0.89, 0.90 at 2, 3, and 5 SD, p < 0.0001 for all regressions)
cohorts. FWHM analysis demonstrated good correlation in the ischemic population (N = 40, r = 0.83, p < 0.0001).
Bland-Altman analysis demonstrated a systematic bias with MIR images showing higher values than PSIR for
ischemic (3.3 %, 3.9 % and 4.9 % at 2, 3, and 5 SD, respectively), and non-ischemic (9.7 %, 7.4 % and 4.1 % at ≥2, ≥3,
and ≥5 SD thresholds, respectively) cohorts. Background myocardial signal measured in the control population
demonstrated a similar bias of 4.4 %, 2.6 % and 0.7 % of the LV volume at 2, 3 and 5 SD thresholds, respectively.
The bias observed using FWHM analysis was −6.9 %.
Conclusions: Scar quantification using phase corrected (PSIR) images achieves values highly correlated to those
obtained on non-corrected (MIR) images. However, a systematic bias exists that appears exaggerated in
non-ischemic cohorts. Such bias should be considered when comparing or translating knowledge between
MIR- and PSIR-based imaging.
Keywords: Cardiovascular magnetic resonance, Late gadolinium enhancement, Scar quantification, Ischemic
cardiomyopathy, Non-ischemic cardiomyopathy, Phase-sensitive inversion recovery (PSIR)
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Background
Late gadolinium enhancement cardiovascular magnetic
resonance (LGE-CMR) is a well-established clinical tool
for the assessment of irreversible myocardial injury or
“scar” in patients with ischemic and non-ischemic cardiomyopathy [1, 2]. Several studies now suggest strong
prognostic utility for the quantification of ischemic scar
signal to predict response to medical [3], surgical [4, 5]
and device therapy [6–8]. Furthermore, in those
with dilated cardiomyopathy (DCM) [9–11] and hypertrophic cardiomyopathy (HCM) [12] the presence and
extent of non-ischemic LGE appears to predict future
cardiovascular events. These studies have employed
signal-threshold based approaches to segment bright scar
signal from the otherwise dark or “nulled” myocardium,
this signal gradient effectively provided by magnitudereconstruction inversion recovery (MIR) imaging, as was
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originally described by Simonetti, et al. [13]. However, due
to this technique’s inherent dependence on accurate prescription of the inversion time (TI) to optimally “null”
normal myocardium [14], an alternative approach called
phase-sensitive inversion recovery (PSIR) has been introduced [15]. This technique exploits collection of a reference phase image on alternating heartbeats which enables
restoration of the voxel polarity using a phase-sensitive reconstruction to correct tissue signal intensities related to
inaccurate TI prescription (Fig. 1). By eliminating a need
for accurate TI prescription this technique has realized
rapid and widespread clinical adoption.
While early validation studies compared basic scar
area measures from PSIR and MIR images (predominantly by visual planimetry) [15–19], the current paradigm of scar signal quantification has not been
appropriately evaluated. Specifically, the effect of PSIR

Fig. 1 Example of quantitative analysis of late enhancement in a patient with a ischemic cardiomyopathy and b non-ischemic cardiomyopathy.
Optimally nulled MIR image (top panel), and matched PSIR image (lower panel) are shown with scar (yellow) identified at 2, 3, and 5 SD thresholds
above the mean signal intensity of normal reference myocardium (shown in blue)
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reconstruction on the behavior of scar volumetry obtained using multi-threshold Signal Threshold versus
Reference Myocardium (STRM) and Full Width Half of
Maximum (FWHM) techniques is unknown. Given the
marked alteration in the range of signal intensities with
phase-sensitive reconstruction [15] it cannot be assumed
that such assessments would be unaffected. If such differences exist, their definition would be of importance
for the design and interpretation of multi-center clinical
trials or registries that include heterogeneous site adoption of the PSIR technique.
The aim of this study was to systematically compare scar volume measurements acquired by currently published signal-threshold techniques obtained
from spatially and temporally matched MIR and
PSIR LGE images in patients with ischemic and nonischemic myocardial scar.

Methods
Patient population

A total of 80 consecutive patients with definite myocardial scar were identified from initial short-axis, free
breathing (single shot) LGE imaging, 40 with ischemic
and 40 with non-ischemic myocardial scar. These patients underwent a standardized, TI-optimized LGE imaging protocol [12, 13] to obtain spatially and temporally
matched PSIR and MIR reconstructed images. In
addition, a control cohort of 40 patients with no identifiable scar was identified to evaluate the effects of PSIR
versus MIR on normal tissue signal and background
image noise. This cohort of patients were all referred for
the exclusion of structural heart disease but determined
to have a normal CMR study.
All patients provided written informed consent, and
the study protocol was approved by the Institutional
Health Research Ethics Board. Patients with an estimated glomerular filtration rate (eGFR) ≤ 30 mL/min/m2
were excluded from this study.
CMR protocol

Patients were scanned using a 3.0 Tesla scanner (TIM
TRIO or Verio; Siemens Medical Systems, Germany)
using a 32-channel phased-array radiofrequency coil.
Cine functional imaging was performed in a standard
fashion using an SSFP-based pulse sequence (TrueFISP)
in sequential short-axis slices from the atrioventricular
annulus to the left ventricular apex at 10 mm intervals
(slice thickness 6 mm, gap 4 mm, TE 1.5 msec, TR 35–
45 msec). At 5–7 min following the administration of
0.2 mmol/kg of gadolinium (Magnevist®, or Gadovist®,
Bayer Inc. Canada) a free-breathing series of short-axis
images were obtained using an SSFP-based “single shot
inversion recovery” pulse sequence (slice thickness
8 mm, gap 2 mm, matrix 192 × 192, TE 1.2 msec, TR
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960 msec, iPAT 2). This allowed for identification of obvious myocardial scar. At 10 min following contrast
breath-held LGE imaging was performed in slice orientations identical to cine imaging using a segmented PSIR
turbo-FLASH pulse sequence with meticulous attention
given to prescribe the TI time to optimally null normal
myocardium, as previously described [14] (matrix 256 ×
192, slice thickness 6 mm, and gap 4 mm, TE 1.4 msec,
TR 760 msec, iPAT 2). Both magnitude and phasesensitive reconstruction of each LGE image were generated, ensuring that images were both temporally and
spatially matched.
CMR image analysis

Cine image datasets (N = 120) were de-identified and
underwent blinded assessment of left ventricular (LV)
end-diastolic and end-systolic volumes using commercially available, semi-automated software (CVI42, Circle
Cardiovascular Inc., Calgary, Canada).
Using the same commercial software MIR and PSIR
LGE image datasets were separately analyzed in random
order. A single set of endocardial and epicardial contours were manually traced from the MIR dataset and
then stored for use for all scar image analyses. This was
done to ensure that signal volume differences were
not introduced from human reproducibility errors. For
STRM-based analyses (all patients) a large contiguous
region of normal (“nulled”) myocardium was identified
(30-50 % of total myocardial area whenever possible) for
each slice, as shown in Fig. 1, and served as the reference for scar segmentation where scar signal is defined
using a selected number of standard deviations (SD)
above the mean reference signal [20, 21]. For this study
we evaluated the most commonly reported ≥2, ≥3 and
≥5SD thresholds. The FWHM technique was incrementally evaluated in the ischemic sub-group (N = 40) with
the densest region of scar (when present) traced for each
slice. This served as a reference where scar was defined
as any voxel with signal ≥50 % of the highest reference
region signal [20]. The FWHM technique was not applied to the non-ischemic cohort as it included patients
with dilated cardiomyopathy for which this technique
may not be appropriate [22]. Total scar volume was
expressed as a percent of the LV myocardial volume, and
was obtained by dividing the summed scar volumes by the
summed myocardial volumes (epicardium minus endocardium) for all analyzed slices.
Due to differences in signal intensity patterns between
matched MIR and PSIR images, FWHM analysis of PSIR
images required the signal intensity (SI) be normalized
to the minimum SI of the myocardium in the PSIR
image. This normalization was required since the signal
intensity of normal myocardium on MIR images is near
0 (i.e. nulled), whereas in the PSIR images, which have
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twice the dynamic range, the myocardial signal is scaled
near the center of the total dynamic range (approximately 1800 for our PSIR sequence).
Statistical analysis

Continuous variables are reported as the mean ± SD, categorical variables as percentage of total. The correlation
between MIR- and PSIR-based scar signal quantification
as a percent of total LV volume was evaluated according
to the Pearson correlation coefficient (r). Bland-Altman
analysis was performed for all comparisons with bias estimated by the mean difference. Statistical analyses were
performed using a commercially available software program (GraphPad Prism, Version 5.0, CA, USA). All
probability values were 2-sided, and a p-value ≤ 0.05 was
considered significant.
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Global myocardial scar burden

Overall, quantitative signal analysis of total myocardial
scar volume identified significantly higher values for
those with ischemic versus non-ischemic injury (Table 2).
For example, by STRM-based analysis (≥5SD) of conventional MIR images the mean total scar volume of ischemic and non-ischemic cohorts was 21.3 % ± 13.0 % and
7.1 ± 7.7 %, respectively (p < 0.01).
Within the control population a measurable native
myocardial signal was identified at all signal thresholds,
supporting that background myocardial signal indeed
contributes to total scar volume quantification using a
regional tissue reference for application of STRM-based
techniques. As shown in Table 2, this appeared modest
at the ≥5SD signal threshold (1.3 ± 0.9 %), but increased
in both absolute and relative contribution as signal
threshold was lowered (6.1 ± 3.1 % at ≥3SD and 13.6 ±
5.6 % at ≥2SD).

Results
Patient characteristics

PSIR versus MIR scar volumes – STRM-based analysis

Baseline patient characteristics are shown in Table 1.
The mean age of the population was 57.9 ± 16.9 years.
The mean ejection fraction (EF) of ischemic, nonischemic and control groups were 35.8 ± 15.9 %, 56.3 ±
20.8 %, and 63.6 ± 15.4 %, respectively. Of patients with
ischemic scar, 29 (72 %) had single coronary territory infarction and 11 (28 %) had ≥2 territories involved.
Among patients with non-ischemic scar, 24 (60 %) had
DCM with typical mid-wall linear scar, 14 (35 %) had
HCM with patchy mid-wall scar and 2 patients (5 %)
had a history congenital heart disease with mid-wall fibrosis at the right ventricular insertion sites.

All study subjects with myocardial scar (N = 80) underwent
multi-threshold STRM-based scar analysis. A strong correlation between PSIR and MIR derived measures of total
scar volume was identified for all 3 signal thresholds. Correlation coefficients for ≥2SD, ≥3SD and ≥5SD thresholds
were 0.93, 0.94, and 0.92, respectively. Bland-Altman analysis revealed a systematic bias for PSIR derived measures
consistently falling below MIR derived measurements at
all 3 thresholds. A mean absolute reduction in total percent scar volume of 6.5 %, 5.7 % and 4.5 % was identified
at ≥2SD, ≥3SD and ≥5SD thresholds, respectively.

Table 1 Baseline patient characteristics for each subgroup
Ischemic

Non-Ischemic

Control

n = 40

n = 40

n = 40

Table 2 Mean late enhancement (±SD) expressed as percent of
total LV volume for each subgroup as measured from optimized
magnitude inversion recovery (MIR) and phase sensitive
inversion recovery (PSIR) images
Ischemic

Non-ischemic

Control

2SD

Patient Characteristics
Age

62.8 ± 15.6

58.2 ± 16.5

52.6 ± 15.2

MIR

37.86 ± 13.64*

27.53 ± 10.42*

13.55 ± 5.55*

Female

9 (22.5 %)

3 (7.5 %)

12 (30.0 %)

PSIR

34.52 ± 13.64

18.21 ± 10.26

9.20 ± 3.72

Hypertension

19 (47.5 %)

16 (40.0 %)

15 (37.5 %)

3SD

Diabetes

7 (17.5 %)

4 (10.0 %)

3 (7.5 %)

MIR

30.08 ± 14.05*

16.58 ± 9.68*

6.06 ± 3.11*

26.14 ± 12.46

9.16 ± 8.70

3.44 ± 1.99

Hyperlipidemia

20 (50.0 %)

14 (35.0 %)

11 (27.5 %)

PSIR

Prior MI

40 (100.0 %)

0 (0.0 %)

0 (0.0 %)

5SD

20 (50 %)

3 (7.5 %)

4 (10 %)

MIR

21.27 ± 12.95*

7.05 ± 7.66*

1.32 ± 0.90*

MRI Parameters

PSIR

16.35 ± 10.05

2.97 ± 5.69

0.65 ± 0.68

LV EDV (mL ± SD)

215.4 ± 71.9

176.7 ± 86.4

160.4 ± 62.4

FWHM

LV ESV (mL ± SD)

145.0 ± 70.0

91.3 ± 83.4

61.8 ± 46.5

MIR

15.41 ± 9.87*

63.6 ± 15.4

PSIR

22.35 ± 14.71

145.8 ± 49.3

SD standard deviation; LV left ventricle; MIR magnitude inversion recovery;
PSIR phase sensitive inversion recovery; FWHM full-width at half-maximum
*p < 0.0001 for comparison between MIR and PSIR by paired-sample t-test at
the respective threshold

Prior Revascularization

LV EF (% ± SD)
LV Mass (g ± SD)

35.8 ± 15.9
171.3 ± 51.2

56.3 ± 20.8
174.3 ± 69.1

MI myocardial infarction; LV left ventricle; EDV end diastolic volume; ESV end
systolic volume; EF ejection fraction
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Similar analysis was performed following stratification
for scar etiology. In those with ischemic scar, excellent
correlation was seen between PSIR and MIR based measures at ≥2SD, ≥3SD and ≥5SD, respective correlation
coefficients being 0.96, 0.95, and 0.88 (p < 0.0001 for all
regressions) (Fig. 2). The mean bias at these thresholds
was 3.3 %, 3.9 %, and 4.9 % (lower for PSIR) (Fig. 3), suggesting no association with the signal threshold selected
(p = 0.36 by ANOVA). By comparison, those with nonischemic scar showed lower correlation coefficients between PSIR and MIR based analysis (0.86, 0.89, and 0.90,
respectively, p < 0.0001 for all regression) (Fig. 2). Although
similarly showing a negative bias for PSIR based scar volumes, an inverse relationship of severity to the signal
threshold selected was evident (9.7 %, 7.4 % and 4.1 % at
≥2, ≥3, and ≥5 SD thresholds, respectively, p < 0.001, by
ANOVA. A summary of these biases is provided in Table 3
with respective Bland-Altman plots shown in Fig. 3.
PSIR versus MIR scar volumes – FWHM-based analysis

Among those with ischemic injury, scar signal quantification
was repeated using the FWHM technique, as previously
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described [20]. Linear regression analysis demonstrated a
good correlation between MIR and PSIR derived total scar
volumes (r = 0.83, p < 0.0001). Bland-Altman analysis
demonstrated a systematic bias between MIR and PSIR
derived measurements of total myocardial scar volume.
However, in contrast to STRM-based imaging, the mean
bias demonstrated a reduction in total scar volume estimates using MIR-based images versus PSIR-based images,
and was estimated to be 6.9 % of the LV mass (Fig. 4).
PSIR versus MIR scar volumes—background myocardial
signal

The influence of PSIR reconstruction on measurable
background myocardial signal was assessed among 40
control patients. As this population lacks visible scar
only STRM-based analysis is applicable. Measurable signal was appreciated in all patients and was inversely related to the threshold employed. Using MIR-based
images the mean total “scar” volume was 13.6 ± 5.6 %,
6.1 ± 3.1 % and 1.3 ± 0.9 % of the LV at ≥2SD, ≥3SD and
≥5SD thresholds, respectively (Table 2). Correlation coefficients for ≥2SD, ≥3SD and ≥5SD thresholds were

Fig. 2 Linear regression analysis comparing myocardial late enhancement volume using MIR and PSIR for STRM-based analysis. Late enhancement
is reported as percent of total LV myocardial volume at 2, 3, and 5 SD from the mean signal intensity of normal reference myocardium
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Fig. 3 Bland-Altman analysis comparing myocardial late enhancement volume using MIR and PSIR for STRM-based analysis. Values indicate the
mean difference of MIR-based scar volume quantification relative to PSIR. Late enhancement is reported as percent of total LV myocardial volume
at ≥2, ≥3, and ≥5 SD from the mean signal intensity of normal reference myocardium. Long dashed lines represent bias, dotted lines represent
95 % confidence intervals

0.33, 0.58, and 0.66, respectively (Fig. 2). Bland-Altman
analysis showed a systematic bias with PSIR images producing a reduction in mean total “scar” volume of 4.4 %,
2.6 %, and 0.7 % of the LV mass at ≥2SD, ≥3SD and
≥5SD thresholds, respectively (Fig. 3).

Discussion
Myocardial scar volume quantification is an established
investigative and emerging clinical tool for the prediction
of adverse clinical outcomes and therapeutic response in
patients with ischemic and non-ischemic cardiomyopathy
[3–8]. To date such evidence is based upon signal

threshold analysis of conventional, MIR-based LGE CMR.
However, rapid and widespread clinical adoption of PSIRbased LGE sequences is being realized following recent
introduction by a majority of hardware vendors. The
current study identifies that signal-threshold based scar
volume quantification should not be considered equivalent
between these techniques, and may lead to clinically relevant differences in scar volume estimations dependent
upon the analysis technique used, signal threshold chosen
or type of scar evaluated.
Our results are at odd with previous studies comparing MIR and PSIR-based scar signal analysis by manual

Table 3 Biases for scar volume using PSIR-based imaging relative to MIR-based imaging. Results are presented as a percent of LV
volume according to Bland-Altman analysis for different etiologies and thresholding techniques
Etiology

ICM

Thresholding technique

Bias

NICM

STRM

FWHM

STRM

2SD

3SD

5SD

FWHM

2SD

3SD

5SD

−3.27

−3.89

−4.87

+6.89

−9.71

−7.41

−4.08

ICM ischemic cardiomyopathy; NICM non-ischemic cardiomyopathy; STRM signal threshold versus reference myocardium; FWHM full-width at half-maximum
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Fig. 4 Linear regression and Bland-Altman analyses comparing myocardial late enhancement volume using MIR and PSIR for FWHM-based
analysis. Late enhancement is reported as percent of total LV myocardial volume at 2, 3, and 5 SD from the mean signal intensity of normal
reference myocardium. Left: Linear regression analysis. Values indicate the mean difference of MIR-based scar volume quantification relative to
PSIR. Right: Bland-Altman analysis. Long dashed lines represent bias, dotted lines represent 95 % confidence intervals

tracing of LGE. In these studies, volume of LGE did not
vary significantly between techniques [15–18]. This may
be explained by the fact that the marked signal profile
change secondary to phase correction is largely unrecognized by visual interpretation as adjustment of
window-level settings automatically re-establishes similar
voxel intensities for the myocardium.
To our knowledge, only one previous study used a signal threshold technique [19] for quantification of LGE
volume. Although the difference was not significant,
LGE volume quantification by MIR-based scar signal
analysis was higher than PSIR values. This study, however had fewer patients and did not assess FWHMbased analysis.
A number of factors likely contribute in a complex
manner to produce the biases identified in this study between PSIR versus MIR-based scar signal analysis. First,
it is anticipated that T1 relaxation properties of the normal myocardium vary to some degree throughout the
heart’s volume as a results of varying tissue composition
and with B1-inhomogeneity [23]. Further, T1 will dynamically change throughout the course of imaging as
gadolinium washes out of the myocardium [24, 25]. Despite careful optimization of the TI time to provide satisfactory nulling in a majority of the myocardium, voxel
heterogeneity in T1 relaxation cannot be accommodated
for using a single TI time prescribed over the entire
myocardium at the onset of imaging. While potentially
not appreciated by visual inspection, inadequately nulled
voxels will receive higher signal using MIR-based reconstruction and, if exceeding a threshold value dictated by
referenced tissue, be labeled as scar.
Second, the distribution of noise within magnitude
and phase-reconstructed images is substantially different. For example, MIR images are typically reconstructed
using multi-channel sum-of-squares, a technique that
produces signal in low SNR regions (i.e. nulled

myocardium) that roughly follows a centric chi-squared
(Rician) distribution, which is positively skewed [25].
This creates the potential for voxels in nulled (ie: normal) myocardium to be misclassified as “scar”, a finding
that was evident in the control population of the current
study. In contrast, PSIR images preserve the polarity information in the data such that the myocardium maintains intermediate signal intensity. The normal
myocardium is therefore “grey” rather than “nulled” (although this is infrequently realized when viewing
window-level adjusted images). Therefore, noise signal is
roughly normally distributed (non-skewed distribution)
within normal myocardium using PSIR imaging [15] and
therefore is less likely to mislabel noise signal as scar.
An interesting observation was that FWHM scar analysis produced an opposite bias for scar signal analysis
than for STRM. This can be theoretically explained by
considering the net influence of signal alterations for reference versus target tissues. The FWHM approach
adopts the maximal signal intensity of scar as its reference signal with 50 % of this signal used as the threshold
above which scar will be defined. The maximal signal
within scar (and hence, the scar signal threshold) varies
modestly when phase reconstruction is applied given
that this high signal is Gaussian in distribution. However, the lower signal ranges of more peripheral scar signal are expected to be shifted more substantially. This
will be intermediate to that experienced by normal or
“nulled” myocardium that is re-set from approximately
zero signal (ie: nulled) to a mid-range signal intensity (ie:
grey) [15]. Overall, this will lead to a higher likelihood of
intermediate signal voxels to be re-classified from “normal” to “scar” using the FWHM approach.
Overall, while in practice the situation is incrementally
more complex with respect to changes in noise statistics,
filtering of the reference image and combination of B1
data from multiple coils [14], the net result is that phase
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reconstruction influences a host of variables that may alter
image signal profiles sufficient that threshold-based quantification may yield dissimilar results versus that performed from matched magnitude-reconstructed images.
Clinical implications

The primary implications of these findings relate to the
planning of future multi-center research initiatives that
may have a heterogeneous adoption of MIR and PSIRbased imaging among recruiting sites. It should be realized
that images obtained using these alternate approaches
might yield a range of differences in scar volume despite
standardized core-laboratory analysis that could reach
clinically relevant levels. For example, among those with
non-ischemic injury, scar volumes differences ranging up
to 9.7 % may be realized using STRM-based analysis. For
those with ischemic injury differences up to 4.9 % by
STRM analysis and 6.9 % by FWHM may be realized.
Practical solutions to this might include the collection of
TI-optimized MIR images in concert with PSIR images (as
performed in the current study), or the correction of scar
volumes by the described bias values.
Study limitations

This study was performed using a 3 Tesla Siemens MR
system coupled with a 32-channel coil. Accordingly, generalizability of these findings to other system configurations
cannot be recommended. Further, the dose and relaxivity
of different gadolinium based contrast agents may contribute to alterations in signal based quantification and was
not tested in this study.

Conclusions
Phase reconstruction of LGE images provides substantial
practical benefits to clinical workflow and has the potential to improve image quality at less experienced centers.
We however identify systematic bias that may be introduced for the performance of signal-threshold based scar
quantification dependent upon both etiology and the
scar threshold technique employed. These findings warrant consideration when planning multi-center research
initiatives and for the translation of scar quantification
into clinical practice.
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